neostigmine has been researched along with Familial Periodic Paralysis in 3 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Excerpt | Relevance | Reference |
---|---|---|
" Mary Walker discovered in 1934 that physostigmine and Prostigmin temporarily restored muscle function in patients with myasthenia gravis." | 3.73 | The contribution of Dr. Mary Walker towards myasthenia gravis and periodic paralysis whilst working in poor law hospitals in London. ( Johnston, JD, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McCarter, SJ | 1 |
Burkholder, DB | 1 |
Klaas, JP | 1 |
Martinez-Thompson, JM | 1 |
Boes, CJ | 1 |
Johnston, JD | 1 |
Stern, FH | 1 |
3 other studies available for neostigmine and Familial Periodic Paralysis
Article | Year |
---|---|
The Mary Walker effect: Mary Broadfoot Walker.
Topics: Cholinesterase Inhibitors; Female; History, 19th Century; History, 20th Century; Humans; Myasthenia | 2019 |
The contribution of Dr. Mary Walker towards myasthenia gravis and periodic paralysis whilst working in poor law hospitals in London.
Topics: Cholinesterase Inhibitors; History, 19th Century; History, 20th Century; Hospitals; Humans; Hypokale | 2005 |
Myasthenia gravis, an often overlooked disease in the geriatric group.
Topics: Adrenal Insufficiency; Aged; Amyotrophic Lateral Sclerosis; Chronic Disease; Curare; Diagnosis, Diff | 1966 |